Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Pilot Study: Proteomics of Primary Hyperoxaluria Type 1 (PH1): A Rare Calcium Oxalate Stone Disease"

NCT03067142 is registered in ClinicalTrials.gov with Ann & Robert H Lurie Children's Hospital of Chicago as lead sponsor.

NCT NCT03067142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03067142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Pilot Study: Proteomics of Primary Hyperoxaluria Type 1 (PH1): A Rare Calcium Oxalate Stone Disease"
Lead sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Phase
Observational
Overall status
Completed
Start date
January 5, 2017
Completion date
May 31, 2019
Enrollment
93 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

primary hyperoxaluria type 1